Renyu Liu

US Patent:

20130102659, Apr 25, 2013

Filed:

Jun 29, 2011

Appl. No.:

13/806068

Inventors:

Renyu Liu - Media PA, US

International Classification:

A61K 31/366

US Classification:

514455, 549280

Abstract:

The invention relates to salvinorin compositions and uses thereof. Specifically, the invention relates to administering a salvinorin compound to produce vasodilatory effect and organ protective effect from hypoxia/ischemia and reperfusion. The invention further relates to treating various diseases or disorders.

US Patent:

20160123919, May 5, 2016

Filed:

Apr 25, 2014

Appl. No.:

14/786674

Inventors:

- Philadelphia PA, US
Jin XI - Media PA, US
Ganghee HAN - Philadelphia PA, US
Mitchell LERNER - Philadelphia PA, US
Jeffery G. SAVEN - Philadelphia PA, US
Renyu LIU - Media PA, US
Felipe MATSUNAGA - Olmsted Township OH, US
Jose Manuel PEREZ-AGUILAR - New York NY, US

Assignee:

The Trustees of The University of Pennsylvania - Philadelphia PA

International Classification:

G01N 27/327
G01N 27/414
C23C 16/44
G01N 27/416
G01N 33/94
G01N 33/543

Abstract:

The present invention provides methods for fabricating field-effect devices and sensor arrays. The field of the invention also pertains to methods of using the sensors individually, in combination, and in array fashion to detect molecules. The present invention also provides for products produced by the methods of the present invention and for apparatuses used to perform the methods of the present invention.

US Patent:

20150366840, Dec 24, 2015

Filed:

Mar 23, 2015

Appl. No.:

14/665755

Inventors:

- Philadelphia PA, US
Renyu LIU - Media PA, US

International Classification:

A61K 31/366
A61K 9/00

Abstract:

The invention relates to salvinorin compositions and uses thereof. Specifically, the invention relates to administering salvinorin compositions to treat diseases and disorders associated with vasoconstriction, vaso-occlusion, or disruption of blood flow and autoregulation. For example, salvinorin compositions may be administered to subjects with cardiac arrest, subarachnoid hemorrhage, stroke, cerebral vascular spasm, cerebral hypoxia/ischemia, cerebral artery occlusion, or any condition involved in autoregulation impairment.